Encounter for screening for malignant neoplasms
- Z12 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM Z12 became effective on October 1, 2024.
- This is the American ICD-10-CM version of Z12 – other international versions of ICD-10 Z12 may differ.
Applicable To
- Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Use Additional
- code to identify any family history of malignant neoplasm (Z80.-)
Type 1 Excludes
- encounter for diagnostic examination-code to sign or symptom
The following code(s) above Z12 contain annotation back-references
that may be applicable to Z12:
- Z00-Z99 Factors influencing health status and contact with health services
- Z00-Z13 Persons encountering health services for examinations
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to Z12:
- Type 2 Excludes: Z13.8